Browsing: amp
Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor
By Admin
Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its…
President Donald Trump’s administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with officials…
Johnson & Johnson’s stock rallies after an earnings beat and raised outlook, lifting pharma stocks
By Admin
Johnson & Johnson’s stock gets a boost from an earnings beat and raised full-year outlook.
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
By Admin
Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it…